High-efficiency nutrient delivery solutions available for immediate private label branding or custom contract manufacturing across Benelux and European markets.
Spore-forming probiotic gummies engineered for gastric acid resistance, optimal microflora balance, and enhanced intestinal adhesion.
Get a Quote
Plant-based phytonutrient matrix combining spirulina, chlorella, and liposomal antioxidants for rapid post-workout cellular recovery.
Get a Quote
High-potency ascorbic acid gummies formulated with citrus bioflavonoids for superior antioxidant defense and systemic absorption.
Get a Quote
Paediatric and family-friendly veggie multivitamin gummy bears delivering bioavailable micronutrients derived from organic greens.
Get a Quote
Concentrated vitamin C soft confectionery designed to promote collagen synthesis, skin illumination, and non-heme iron absorption.
Get a Quote
Hydrolysed collagen peptides synergised with hyaluronic acid and liposomal vitamin E for target nutricosmetic beauty-from-within lines.
Get a Quote
Advanced 5-MTHF folate, methylcobalamin, CoQ10, and TMG liposomal complex supporting cellular energy, methylation, and cardiovascular health.
Get a Quote
Custom-formulated pediatric chewables tailored to meet strict European food safety guidelines, delivering essential vitamins without artificial dyes.
Get a QuoteWhy traditional nutrient delivery is losing market share to lipid bilayer nano-encapsulation across European clinical and commercial nutraceutical sectors.
The European dietary supplement landscape is undergoing a structural shift driven by informed consumers, clinical practitioners, and stringent regulatory benchmarks enforced by agencies such as the European Food Safety Authority (EFSA) and the Belgian Federal Public Service (FPS) Health, Food Chain Safety and Environment. Standard oral supplement formats—such as compressed tablets and unencapsulated crystalline powders—frequently exhibit poor intestinal bioavailability. Water-soluble actives like Vitamin C (ascorbic acid) suffer from saturable intestinal transporters (SVCT-1), leading to rapid renal excretion when administered at high doses. Meanwhile, fat-soluble compounds like Vitamin D3, Vitamin K2, and Coenzyme Q10 face significant dissolution barriers in gastrointestinal fluids.
As a specialized liposomal vitamins supplier & contract manufacturer serving Belgium and the broader Benelux region, Q Nutritions bridges the gap between pharmaceutical delivery science and commercial supplement manufacturing. Liposomal technology utilises a phospholipid bilayer structure—analogous to human cellular membranes—to encapsulate active micronutrients within a protective hydrophobic or hydrophilic core. This structural architecture shields fragile active molecules from enzymatic degradation in saliva, acidic hydrolysis in the stomach, and bile salt emulsification in the duodenum, delivering the encapsulated payload directly to epithelial cells for lymphatic uptake.
Comparative physiological dynamics based on clinical uptake studies, intracellular retention curves, and gastrointestinal degradation profiles.
| Delivery Parameter | Standard Oral Supplements | Liposomal Bilayer Delivery (Q Nutritions) | Clinical Gain Factor |
|---|---|---|---|
| Intestinal Bioavailability | 12% – 20% (Saturable transport) | 85% – 95% (Direct cellular fusion & lymphatic transport) | Up to 5.2x Higher Peak Area-Under-Curve (AUC) |
| Gastric Stability (pH 1.5 - 2.0) | Rapid chemical degradation / oxidation | Phospholipid shield resists acid hydrolysis | Complete Payload Protection |
| Plasma Half-Life ($t_{1/2}$) | 1.5 – 3.0 Hours (Fast renal clearance) | 6.0 – 12.0 Hours (Sustained circulating vesicles) | 3x Extended Therapeutic Window |
| Cellular Uptake Mechanism | Passive diffusion / Carrier dependency | Endocytosis / Phospholipid cell membrane fusion | Bypasses First-Pass Hepatic Metabolism |
| Gastrointestinal Tolerance | May cause nausea, cramping, osmotic diarrhea | High mucosal tolerance; gentle on gastric lining | Zero Osmotic Distress at Clinical Doses |
Navigating consumer preferences, pharmacy distribution structures, and regulatory compliance (NUT Notifications) in Belgium.
Belgian consumers demonstrate high trust in pharmacy-led nutraceutical purchases (e.g., independent apotheken and networks across Antwerp, Ghent, and Liège). We supply fully documented batch dossiers, Certificates of Analysis (COA), and stable liposomal liquid/gummy lines that meet pharmaceutical standards required by Belgian health practitioners.
Under the Royal Decree of 3 March 1992, placing food supplements on the Belgian market requires prior notification to the Belgian FPS Public Health (creating a unique NUT/DEG number). Q Nutritions provides complete ingredient origin mapping, maximum dosage verification, and label artwork compliance assistance for rapid authorization.
Utilising strategic logistics corridors linking Flanders to Rotterdam and Liège Airport, our export packaging is optimized for temperature-stable sea and air freight. Liquid and soft-gel liposomal SKUs feature nitrogen flushing and barrier foil seals to withstand ambient humidity fluctuations during European distribution.
Brussels and Flemish longevity clinics increasingly prescribe high-dose Liposomal Glutathione, Liposomal CoQ10, and Methylated B-Complex formats. We manufacture custom clinical-grade formulas with precise 100-200nm vesicle distribution, validated via Dynamic Light Scattering (DLS) testing.
Belgian DTC e-commerce brands demand non-GMO sunflower lecithin carriers (eliminating soy allergens), natural monk fruit or maltitol sweetening, and pectin-based vegan gummy shells. Our production lines feature segregated allergen containment and verified non-animal gelatin capabilities.
For Belgian brands seeking fast turnarounds, our pre-formulated stock liposomal softgels, gummies, and liquid concentrates allow rapid brand launching in as little as 6 to 8 weeks, backed by Health Canada Site Licences and US FDA facility registrations.
Every batch produced for Belgian importers undergoes rigorous in-house and third-party laboratory verification to guarantee purity, stability, and label accuracy.
Manufacturing stable liposomal formulas requires specialized homogenization, microfluidization, and lipid-phase temperature management. Unstable liposomes tend to aggregate, leak their active nutrient payload, or undergo premature phase separation. At Q Nutritions, our Canadian headquarters in Mississauga, Ontario—complemented by global GMP facilities—operates under a stringent Quality Management System (QMS) aligned with Health Canada Natural Health Products Directorate (NHPD) guidelines, US FDA 21 CFR Part 111, and ISO 22000 standards.
Non-GMO sunflower phosphatidylcholine (PC > 70%) sourced and identity-verified via NMR spectroscopy.
Active ingredients encapsulated under controlled shear stress to achieve uniform 100-200nm spherical vesicles.
Dynamic Light Scattering (DLS) confirms particle size distribution; HPLC validates entrapment efficiency (> 90%).
ICP-MS screens for lead, cadmium, mercury, and arsenic; full USP/EP microbiological release assays.
Batch Records, Certificate of Analysis (COA), Free Sale Certificates, and EU-ready labelling released for shipment.
Everything you need to know about custom liposomal manufacturing, minimum order quantities, regulatory dossiers, and Benelux distribution.
For standard liposomal softgels and encapsulated capsules, our production MOQs start at 1,000 units for private label formulations. For custom pectin gummies (such as our Vitamin C or Methylated B-Complex SKUs), baseline runs start at 5,000 bottles. We also offer low-volume pilot batches (500-1,000 liters for liquid liposomes) specifically designed for clinical trials, stability testing, and initial market validation in Belgium.
Liposomal formulations can be sensitive to elevated storage temperatures. We mitigate physical degradation through nitrogen sparging during filling (to eliminate dissolved oxygen), adding natural tocopherols as lipid antioxidants, and employing multi-layer amber PET or glass bottles with induction-sealed barrier liners. Shipments destined for Belgium are dispatched via climate-monitored logistics to ensure liposomes maintain structural integrity from factory floor to Benelux warehouses.
Yes. Our internal Regulatory Affairs team prepares full technical specifications required for Belgian notification dossiers under the Royal Decree of 3 March 1992. This includes full quantitative formulation breakdowns, active vitamin elemental conversions, botanical plant extract ratios, heavy metal/pesticide residual certificates, and dual Dutch/French label artwork compliance reviews (vital for distribution in both Flanders and Wallonia).
We primarily utilize premium non-GMO sunflower-derived phosphatidylcholine (PC), which is naturally soy-free, gluten-free, and allergen-compliant under EU Regulation (EU) No 1169/2011. For specialized formulations requiring specific lipid profiles, we can also formulate using purified non-GMO soy lecithin or hydrogenated phosphatidylcholine matrixes upon request.
For standard private label SKUs using pre-tested stock formulas, turnkey production and packaging take approximately 6 to 8 weeks. Fully custom R&D projects—involving custom flavour development (e.g., natural Belgian berry or citrus profiles), pilot batch testing, Dynamic Light Scattering liposome sizing, and regulatory dossier compilation—typically require 8 to 12 weeks from final specification sign-off.
Entrapment efficiency (EE%) measures the percentage of active nutrient securely enclosed within the lipid bilayers versus free nutrient in the aqueous phase. We utilize centrifugal ultrafiltration combined with High-Performance Liquid Chromatography (HPLC) to separate non-encapsulated actives. Our commercial liposomal standards guarantee an entrapment efficiency of >90% at the time of release, ensuring true liposomal delivery rather than simple physical mixtures.
Expand your product catalog in Belgium and the Benelux region with clinically proven, highly bioavailable liposomal formulations engineered to GMP excellence.
